Regenerative Medicine Therapy in Malaysia: An Update
April 2022
in “
Frontiers in Bioengineering and Biotechnology
”
Studysummary This review highlights the potential of regenerative medicine therapies, particularly stem cells, in treating a range of chronic diseases and injuries, while also discussing advancements and limitations in their application in Malaysia compared to other Asian countries. Our plain-language summary of this paper — not a Tressless recommendation.
The document reviewed the state of regenerative medicine therapy (RMT) in Malaysia, highlighting its potential in tissue and organ regeneration, with a focus on stem cell therapy, tissue engineering, and biomaterials. It noted the growth of medical tourism, with 1.3 million medical tourists in 2019, and discussed applications in treating diseases and aesthetic conditions like alopecia. Despite promising developments, challenges such as cultural diversity, limited clinical evidence, and regulatory gaps were noted. The document emphasized the need for more detailed regulations and highlighted ongoing research and clinical trials, particularly in blood cancer treatment using hematopoietic stem cells. While Malaysia was behind other developed nations, it was making progress in RMT research and applications.
